Protecting IP Rights in Joint Development Agreements and Strategic Alliances

Mr. Tantleff, CIPP/E, is a partner in Foley’s Technology Transactions, Cybersecurity, and Privacy; and the Environmental, Social, and Corporate Governance (ESG) practice groups. He represents companies in various technology, privacy, security, information management, open source, and intellectual property matters, such as the development of compliance policies, programs, cybersecurity breach preparation, incident response, big data, and data monetization initiatives. Mr. Tantleff also regularly represents clients in mergers and acquisitions, outsourcing transactions, strategic alliances, development and licensing arrangements, supply and distribution arrangements, and other strategic and collaborative transactions involving significant technology and intellectual property. He  is a frequent speaker on technology, security, privacy, and outsourcing matters, and is regularly quoted in The Wall Street Journal, Reuters, Politico, Fortune, and other top-tier publications on topics such as cyberattacks, privacy law developments, and data protection, including regarding the General Data Protection Regulation (GDPR) and the Asia Pacific Cross Border Privacy Rules. Mr. Tantleff has been retained for data protection, cybersecurity, monetization of big data/IoT programs, and data breach response, remediation, and simulations by companies across all industries and sizes, domestically and abroad, including several Fortune 100 companies. He has also counseled several state legislators on cybersecurity legislation.

Ms. Prysant represents clients, from startups to multinational companies, in the areas of: technology and intellectual property development, acquisition, protection, and commercialization (including computer information systems, telecommunications, and engineering); consulting and other business services agreements; and life sciences counseling and transactions (including clinical studies, sponsored research and technology transfer for biotechnology, medical device and pharmaceutical companies). She has negotiated complex contracts and manage large-scale transactions from inception through completion, including transactions exceeding $200,000,000.